ProQuest Investments IV, L.P., 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 302,080 shares at $77.13 ($24.0M) on 2016-11-09, disclosed to the SEC on 2016-11-09.
Open-market sale of $24.0M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.39 | 5,030 | $379K | 1.6% |
| 2 | $75.39 | 5,030 | $379K | 1.6% |
| 3 | $75.70 | 1,380 | $104K | 0.4% |
| 4 | $76.49 | 11,690 | $894K | 3.7% |
| 5 | $76.49 | 11,690 | $894K | 3.7% |
| 6 | $77.13 | 9,030 |
| $696K |
| 2.9% |
| 7 | $77.13 | 9,030 | $696K | 2.9% |
| 8 | $78.23 | 4,200 | $329K | 1.4% |
| 9 | $79.24 | 19,581 | $1.6M | 6.5% |
| 10 | $79.24 | 19,581 | $1.6M | 6.5% |
| 11 | $80.09 | 102,919 | $8.2M | 34.4% |
| 12 | $80.09 | 102,919 | $8.2M | 34.4% |
| Total | $79.32 avg | 302,080 | $24.0M | 100% |
| Filing → |
| EGRX | SELL | 2016-09-23 | $13.2M | — | Filing → |
| EGRX | SELL | 2016-08-25 | $1.8M | — | Filing → |
| EGRX | SELL | 2016-08-17 | $6.1M | — | Filing → |